[go: up one dir, main page]

NO984190D0 - Fremgangsmåte for behandling av insomnia - Google Patents

Fremgangsmåte for behandling av insomnia

Info

Publication number
NO984190D0
NO984190D0 NO984190A NO984190A NO984190D0 NO 984190 D0 NO984190 D0 NO 984190D0 NO 984190 A NO984190 A NO 984190A NO 984190 A NO984190 A NO 984190A NO 984190 D0 NO984190 D0 NO 984190D0
Authority
NO
Norway
Prior art keywords
insomnia
procedure
treatment
Prior art date
Application number
NO984190A
Other languages
English (en)
Other versions
NO984190L (no
Inventor
Pierre V Tran
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9606731.9A external-priority patent/GB9606731D0/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO984190D0 publication Critical patent/NO984190D0/no
Publication of NO984190L publication Critical patent/NO984190L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO984190A 1996-03-11 1998-09-11 FremgangsmÕte for behandling av insomnia NO984190L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1312696P 1996-03-11 1996-03-11
GBGB9606731.9A GB9606731D0 (en) 1996-03-29 1996-03-29 Method for treating insomnia
PCT/US1997/003592 WO1997033587A1 (en) 1996-03-11 1997-03-07 Method for treating insomnia

Publications (2)

Publication Number Publication Date
NO984190D0 true NO984190D0 (no) 1998-09-11
NO984190L NO984190L (no) 1998-09-11

Family

ID=26309028

Family Applications (1)

Application Number Title Priority Date Filing Date
NO984190A NO984190L (no) 1996-03-11 1998-09-11 FremgangsmÕte for behandling av insomnia

Country Status (15)

Country Link
EP (1) EP0795330A1 (no)
JP (1) JP2000506528A (no)
KR (1) KR19990087712A (no)
CN (1) CN1212627A (no)
AU (1) AU724245B2 (no)
BR (1) BR9708181A (no)
CA (1) CA2248758A1 (no)
CZ (1) CZ290198A3 (no)
EA (1) EA000793B1 (no)
IL (1) IL126160A0 (no)
NO (1) NO984190L (no)
NZ (1) NZ331846A (no)
TR (1) TR199801800T2 (no)
WO (1) WO1997033587A1 (no)
YU (1) YU40098A (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA86265C2 (uk) * 2004-09-21 2009-04-10 Хипнион, Инк. Аналог локсапіну та його застосування для регулювання сну

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5229382A (en) * 1990-04-25 1993-07-20 Lilly Industries Limited 2-methyl-thieno-benzodiazepine
EG23659A (en) * 1995-03-24 2007-03-26 Lilly Co Eli Process and crystal forms of methyl-thieno-benzodiazepine

Also Published As

Publication number Publication date
JP2000506528A (ja) 2000-05-30
BR9708181A (pt) 1999-07-27
NZ331846A (en) 2000-07-28
WO1997033587A1 (en) 1997-09-18
CN1212627A (zh) 1999-03-31
CZ290198A3 (cs) 1999-09-15
EA199800818A1 (ru) 1999-02-25
NO984190L (no) 1998-09-11
EA000793B1 (ru) 2000-04-24
TR199801800T2 (xx) 1998-12-21
AU2198997A (en) 1997-10-01
AU724245B2 (en) 2000-09-14
CA2248758A1 (en) 1997-09-18
KR19990087712A (ko) 1999-12-27
EP0795330A1 (en) 1997-09-17
YU40098A (sh) 1999-09-27
IL126160A0 (en) 1999-05-09

Similar Documents

Publication Publication Date Title
NO983284D0 (no) Antikoagolante midler egnet i behandling av trombose
NO991381D0 (no) Kombinasjonsterapi for behandling av psykoser
NO991955L (no) FremgangsmÕte for behandling av hydrokarboner
NO984431D0 (no) FremgangsmÕte for behandling av smerte
NO971015D0 (no) Forbindelser og metoder for behandling av cancer
NO976063D0 (no) Fremgangsmåte for behandling av diabetes
FI964874A0 (fi) Vihannesten käsittely
NO982172D0 (no) Anvendelse av epinastin for behandling av smerter
NO986052D0 (no) Antikonvulsive derivater for behandling av fedme
ATE235481T1 (de) Substituierte benzopyranderivate zur behandlung von entzündungen
FI971568A0 (fi) Menetelmä resistenttien kasvainten hoitamiseksi
ID27191A (id) Metode untuk pengobatan insomnia
NO20003042L (no) FremgangsmÕte for profylaktisk behandling av mastitt
NO991459L (no) Anvendelse av 1-hydroksy-2-pyridoner til behandling av hudinfeksjoner
ATE347372T1 (de) Vakzine zur behandlung von mycosen
NO983512D0 (no) Midler for behandling og forhindring av AIDS
NO984432D0 (no) FremgangsmÕte for behandling av migrenesmerte
NO20010456D0 (no) Triazolopyridiner for behandling av trombose-problemer
NO984446D0 (no) FremgangsmÕte for behandling av smerte
NO991734D0 (no) Pyrazolinoner for behandling av potensforstyrrelser
DE69834937D1 (de) Antibiotika zur behandlung von magengeschwuren
NO982582D0 (no) FremgangsmÕte for behandling av smerte
NO973366D0 (no) Fremgangsmåte for behandling av multippel sklerose
NO982562D0 (no) Sammensetning for behandling av smerte
NO20003481D0 (no) FremgangsmÕte for behandling av COPD

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application